Novonesis issues EUR 1.7 billion senior unsecured notes

On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the "Notes"). The issuance was completed under the newly established EUR 4 billion Euro Medium Term Note (EMTN) Programme, dated March 10, 2026.

The Notes will be issued on March 19, 2026, and listed on the Luxembourg Stock Exchange. This inaugural issuance consists of three tranches with maturities ranging from 4 to 11 years and fixed interest rates ranging from 3.25% to 4.00%.

Novonesis has been rated A- (stable outlook) by Standard & Poor's (S&P).



The net proceeds from the transaction will be used to refinance existing debt and for general corporate purposes.

For further details about the EMTN Programme and this issuance, please visit our .

Contact information

Investor Relations                                                      

Tobias Bjorklund                                                            

Anders Enevoldsen                                                        

Treasury                                         

Frants Bisgaard Pedersen                                             

Media Relations                            

Jens Gamborg                                                                 

Attachment